-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UdaGVfgtsx8iyvlwkDksQtiGEo0USS+Xk3tZY140RiQsnVnr4NuOUIlhZBX70RCE PFl+1nCmCRJPGJ8OpXkLzA== 0000945769-06-000036.txt : 20060213 0000945769-06-000036.hdr.sgml : 20060213 20060213170045 ACCESSION NUMBER: 0000945769-06-000036 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060213 DATE AS OF CHANGE: 20060213 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SELTZER REUBEN CENTRAL INDEX KEY: 0001142334 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: C/O TASHLIK, KREUTZER, GOLDWYN & CRANDEL STREET 2: 833 NORTHERN BLVD. CITY: GREAT NECK STATE: NY ZIP: 11021-5308 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: HI TECH PHARMACAL CO INC CENTRAL INDEX KEY: 0000887497 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 112638720 STATE OF INCORPORATION: NY FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-43074 FILM NUMBER: 06604533 BUSINESS ADDRESS: STREET 1: 369 BAYVIEW AVENUE CITY: AMITYVILLE STATE: NY ZIP: 11701 BUSINESS PHONE: 5167898228 MAIL ADDRESS: STREET 1: 369 BAYVIEW AVE. CITY: AMITYVILLE STATE: NY ZIP: 11701 SC 13G 1 sch13g2005-rseltzer.txt SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* HI-TECH PHARMACAL CO., INC. ------------------------------------------------------------- (Name of Issuer) COMMON STOCK ------------------------------------------------------------- (Title of Class of Securities) 42840B101 ------------------------------------------------------------- (CUSIP Number) December 31, 2005 ------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 7 pages CUSIP NO. 42840B101 13G Page 2 of 7 Pages 1. Name of Reporting Persons: Reuben Seltzer I.R.S. Identification Nos. of above persons (entities only): 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) Not applicable 3. SEC Use Only 4. Citizenship or Place of Organization: United States 5. Sole Voting Power NUMBER OF SHARES 872,998 * BENEFICIALLY 6. Shared Voting Power 346,140 * OWNED BY EACH 7. Sole Dispositive Power REPORTING PERSON 872,998 * WITH 8. Shared Dispositive Power 346,140 * 9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,219,138 * 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] 11. Percent of Class Represented by Amount in Row (9) 9.0% 12. Type of Reporting Person (See Instructions) IN * Number of shares reflects a 3 for 2 stock split to shareholders of record on 12/30/05 and distributed on 1/11/06. CUSIP NO. 42840B101 13G Page 3 of 7 Pages UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 4) Under the Securities Exchange Act of 1934 HI-TECH PHARMACAL CO., INC. (Name of Issuer) Item 1(a) Name of Issuer: Hi-Tech Pharmacal Co., Inc. Item 1(b) Address of Issuer's Principal Executive Offices: 369 Bayview Avenue, Amityville, New York 11701 Item 2(a) Name of Person Filing: Reuben Seltzer Item 2(b) Address of Principal Business Office or, if none, Residence: 369 Bayview Avenue, Amityville, New York 11701 Item 2(c) Citizenship: United States Item 2(d) Title of Class of Securities: Common Stock CUSIP NO. 42840B101 13G Page 4 of 7 Pages Item 2(e) CUSIP Number: 42840B101 Item 3 If this statement is filed pursuant to ss.240.13d-1(b) or 240.13d-2(b) or (c), check whether the person is a: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance Company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [ ] Investment Company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) [ ] An investment adviser in accordance with ss.240.13d-1(b)(1)(ii)(E). (f) [ ] An employee benefit plan or endowment fund in accordance with ss.240.13d-1(b)(1)(ii)(F). (g) [ ] A parent holding company or control person in accordance with ss.240.13d-1(b)(ii)(G). (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813). (i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3). (j) [ ] Group, in accordance with ss.240.13d-1(b)(1)(ii)(J). Not applicable CUSIP NO. 42840B101 13G Page 5 of 7 Pages Item 4 Ownership: Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount Beneficially Owned: 1,219,138 * ............................................................ (b) Percent of Class: 9.0% ............................................................ (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote .................872,998* (ii) Shared power to vote or to direct the vote ...............346,140* (iii)Sole power to dispose or to direct the disposition of ....872,998* (iv) Shared power to dispose or to direct the disposition of ..346,140* * Number of shares reflects a 3 for 2 stock split to shareholders of record on 12/30/05 and distributed on 1/11/06. Item 5 Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ]. Item 6 Ownership of More than Five Percent on Behalf of Another Person: Not applicable CUSIP NO. 42840B101 13G Page 6 of 7 Pages Item 7 Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company: Not applicable Item 8 Identification and Classification of Members of the Group: Not applicable Item 9 Notice of Dissolution of Group: Not applicable Item 10 Certification: Not applicable CUSIP NO. 42840B101 13G Page 7 of 7 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 13, 2006 /s/Reuben Seltzer ------------------------------------- -----END PRIVACY-ENHANCED MESSAGE-----